Understanding how collagen is processed in lung fibrosis
Intracellular Collagen Sensing in Pulmonary Fibrosis
This study is looking into how the lungs build up collagen in people with Idiopathic Pulmonary Fibrosis (IPF), which makes it hard to breathe, and aims to find new ways to help clear that collagen to improve treatment options for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10980079 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind collagen accumulation in Idiopathic Pulmonary Fibrosis (IPF), a condition that leads to severe breathing difficulties and lung damage. By using advanced CRISPR screening techniques, the study aims to identify how cells sense and regulate collagen levels, which could help in developing new therapies to promote collagen clearance in patients with IPF. The research focuses on a specific protein that plays a crucial role in this process, potentially leading to breakthroughs in treatment options for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Idiopathic Pulmonary Fibrosis who are experiencing symptoms such as breathlessness.
Not a fit: Patients with other forms of lung disease or those without a diagnosis of Idiopathic Pulmonary Fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that reverse lung fibrosis and improve breathing in patients with IPF.
How similar studies have performed: Other research has shown promise in understanding collagen dynamics in fibrosis, but this specific approach using CRISPR technology is relatively novel.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Podolsky, Michael — Weill Medical Coll of Cornell Univ
- Study coordinator: Podolsky, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.